Dr. Stephen Cary

New brain cancer treatment targets tumor hypoxia to make radiation therapy work better

Omniox, Inc. is a biopharmaceutical company with a new protein-based platform (H-NOX) that has been engineered to make radiation therapy more effective for certain brain tumors. The lead H-NOX product (OMX-4.80) is being developed in partnership with UC San Francisco Division of Neurooncology and is funded by a $7.5 million grant from the National Cancer […]

By Sandra Lobo

A Deep-dive Into Specialty Pharma

A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.

By PurpleLab

With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?

Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.